Notes on Adenylate Cyclase Toxin and Pertussis Toxin Research

Overview of the Study

  • Focus on the adenylate cyclase toxin (ACT) of Bordetella pertussis
  • Research aimed at utilizing ACT to deliver the S1 subunit of pertussis toxin (PT), fostering cytotoxic T lymphocyte responses.

Introduction to Adenylate Cyclase Toxin (ACT)

  • ACT Characteristics:

  • RTX toxin composed of 1706 amino acids.

  • Converts intracellular ATP to cyclic AMP via high calmodulin-dependent adenylyl cyclase activity.

  • Mechanism of Action:

  • Internalizes the catalytic domain into target cells independent of endocytosis (requires calcium).

  • Uses the C-terminal region for invasive activity, with the hemolysin domain assisting in forming pores in membranes.

  • Receptor Interactions:

  • αMβ2 integrin as a recognized receptor in nucleated cells.

Pertussis Toxin (PT) Overview

  • Structure: Heterohexamer comprising several subunits (S1, S2, S3, S4, S5).
  • Functionality:
  • S1 subunit is vital for enzyme activity affecting target cells by ADP-ribosylation and other biological activities.

Study Design and Techniques

  • Objective: Determining if ACT can effectively deliver the S1 subunit into mammalian cells, maintaining functional enzymatic activity.
  • Key Techniques Used:
  • Fusion protein construction, immunoblotting, and cellular assays (e.g., CHO cell clustering).

Methods

  • Protein Production: Recombinant DNA technology to construct fusion proteins between ACT and S1 subunit of PT.
  • Purification: Proteins were extracted and purified using various chromatography techniques.
  • Cellular Interactions: Experiments assessed internalization of fusion toxins in sheep erythrocytes and CHO cells.

Results

  • Internalization Assays:

  • S1C180CyaA (a fusion protein) appeared to internalize successfully in erythrocytes, while S1matCyaA (another variant) did not show significant internalization.

  • Enzymatic Activity:

  • Both fusion toxins demonstrated ADP-ribosyltransferase activity indicating functional enzyme delivery.

  • Cell Morphology Observations:

  • Induction of clustering in CHO cells post-treatment with fusion toxins, confirming interaction and biological response similar to PT.

Discussion

  • Significance of Results:
  • ACT is confirmed as a versatile delivery mechanism for both peptide epitopes and enzymatically active proteins into mammalian cells.
  • Results suggest that ACT-mediated delivery can induce immune responses by facilitating effective antigen presentation.

Conclusion

  • ACT not only delivers antigens but also functional proteins effectively, indicating its potential as a tool for vaccine development and therapeutic protein delivery.